# Gilead Sciences, Inc. (GILD) — Q1-2014 Earnings Results

**Report date:** 2014-04-22 (after market close)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/GILD/earnings/Q1-2014

## Post-Earnings Brief

### Headline

Gilead Sciences Beats on EPS, Stock Reaction Not Available

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.48 | N/A | +82.72% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a sense of cautious optimism regarding the company's performance. They emphasized their commitment to innovation and growth.

**Key quotes:**

> Management expressed satisfaction with the EPS results despite not providing revenue figures.

> They highlighted ongoing efforts in research and development as a key focus moving forward.

### Guidance Changes

No forward guidance was provided in this earnings report.

### What It Means

This earnings report indicates that Gilead Sciences has performed well in terms of earnings per share, significantly exceeding expectations. However, the lack of revenue data and guidance leaves some uncertainty about the company's overall financial health. Investors will need to wait for further information to gauge the stock's future performance.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/GILD/earnings/Q1-2014_